MedTrace Logo

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

NCT06695039 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2025-12-02

No results posted yet for this study

Summary

This study aims to explore the diagnostic performance of \[18F\]FES PET/CT for the evaluation of axillary lymph node metastasis in patients with ER-positive breast cancer having clinically suspected or confirmed axillary lymph node metastasis.

Conditions

  • Breast Cancer Invasive

Interventions

DIAGNOSTIC_TEST

Fluoroestradiol (18F)

images for 90 minutes after F-18 FES injection

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Sangwon Han, Clinical assistant professor · Asan Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-18
Primary Completion
2025-10-02
Completion
2025-10-02

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06695039 on ClinicalTrials.gov